Statistics for Early Use of the NMDA Receptor Antagonist Ketamine in Refractory and Superrefractory Status Epilepticus
Total visits
| views | |
|---|---|
| Early Use of the NMDA Receptor Antagonist Ketamine in Refractory and Superrefractory Status Epilepticus | 357 |
Total visits per month
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 1 |
File Visits
| views | |
|---|---|
| CCRP.2015.831260.pdf | 321 |
| CCRP.2015.831260.xml | 74 |
Top country views
| views | |
|---|---|
| United States | 177 |
| Canada | 51 |
| Germany | 35 |
| Ireland | 15 |
| China | 9 |
| Finland | 5 |
| United Kingdom | 4 |
| Vietnam | 3 |
| France | 2 |
| Cyprus | 1 |
| Estonia | 1 |
| Japan | 1 |
| Nigeria | 1 |
| Singapore | 1 |
Top city views
| views | |
|---|---|
| Ashburn | 142 |
| Winnipeg | 43 |
| Dublin | 15 |
| Inglewood | 6 |
| Brooklyn | 5 |
| Steinbach | 5 |
| Beijing | 4 |
| Hanoi | 3 |
| Helsinki | 3 |
| Burton-on-Trent | 2 |
| Landshut | 2 |
| Offenburg | 2 |
| Seattle | 2 |
| Zhengzhou | 2 |
| Ann Arbor | 1 |
| Boardman | 1 |
| Chandler | 1 |
| Chicago | 1 |
| Des Moines | 1 |
| Frankfurt am Main | 1 |
| Halifax | 1 |
| Heidelberg | 1 |
| Kingston | 1 |
| Lagos | 1 |
| Los Angeles | 1 |
| Mannheim | 1 |
| Morlenbach | 1 |
| Mountain View | 1 |
| Mudau | 1 |
| Nagold | 1 |
| Phoenix | 1 |
| Shanghai | 1 |
| Shenyang | 1 |
| Singapore | 1 |
| Tokyo | 1 |
| Vechta | 1 |
| Winkler | 1 |